The state of Florida's COVID-19 vaccine rollout has been met with various challenges, ranging from supply issues, communication challenges, and disordered distribution plans.
The U.S. Centers for Disease Control and Prevention (CDC) clarified there is no "USA variant" of COVID-19, contradicting the White House coronavirus task force's report on such variant.
Dr. Anthony Fauci, the nation's top infectious disease expert, predicted on Thursday that the COVID-19 pandemic in the U.S. would continue to get worse in the weeks to come.
A new study focusing on COVID-19 immunity study that was recently published by the Centers for Disease Control and Prevention suggests that asymptomatic patients and those with mild COVID-19 cases will develop strong immune responses that can be traced through antibody tests.
Researchers said Thursday that the Sinovac, the COVID-19 vaccine developed by a Chinese firm, was 78 percent effective in a late-stage Brazilian trial, but experts ask for more details.
Moderna CEO Stephane Bancel revealed at a virtual event on Thursday how long the firm's COVID-19 vaccine might prevent infection against the infectious disease caused by the new coronavirus.
Posts on social media said a law allowed all kids in the United States as young as 11 years old to get vaccinated without parental consent, a claim that is mostly false.
The Centers for Disease Control and Prevention (CDC) recently released a statement about what people commonly did before they tested positive for COVID-19.
The World Health Organization has issued a reprimand to China for delaying the entry of travel experts to the country in hopes to prove the origin of the virus. The rebuke was a rare public criticism from the international organization.
Dr. Peter Hotez, Co-Director of the Center for Vaccine Development at Texas Children's Hospital, said that the federal government should set clear goals on how many people need to be vaccinated each day and put less highlight on phased eligibility if it interferes with the timeline.
Brazil's health regulator Anvisa approved two million doses of AstraZeneca vaccine imports from India on late Saturday even though the jab is yet to be approved for use in the country.
